Lifeboat Foundation

IBM scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale and could help enable physicians to detect diseases such as cancer before symptoms appear.

As reported today in the journal Nature Nanotechnology*, the IBM team’s results show size-based separation of bioparticles down to 20 nanometers (nm) in diameter, a scale that gives access to important particles such as DNA, viruses and exosomes. Once separated, these particles can be analyzed by physicians to potentially reveal signs of disease even before patients experience any physical symptoms and when the outcome from treatment is most positive. Until now, the smallest bioparticle that could be separated by size with on-chip technologies was about 50 times or larger, for example, separation of circulating tumor cells from other biological components.

IBM is collaborating with a team from the Icahn School of Medicine at Mount Sinai to continue development of this lab-on-a-chip technology and plans to test it on prostate cancer, the most common cancer in men in the U.S.

Continue reading “IBM lab on a chip can sort 20 nanometer nanoparticles such as DNA, viruses and exos” »

Click on photo to start video.

Porsche concept electric Mission E car.

Continue reading “Porsche concept electronic Mission E car” »

The VASIMR engine being developed by Costa Rican physicist Franklin Chang Díaz is one step closer to proving itself the best technology for propelling the next generation of spacecraft.

It’s the feel good Autopilot story Tesla has been waiting for.

This pill could change treatment for type 2 diabetes forever.

The rapid growth of the world’s human population raises the issue of more efficient food production; one solution to the problem is “clean meat,” which is produced in the equivalent of meat fermenters, Bruce Friedrich, Executive Director of the Good Food Institute, told Radio Sputnik.

The world’s human population reached 7.4 billion in March 2016, having reached 7 billion in October 2011. In 2050, it is expected to reach 9.7 billion, raising the question of how to produce enough food for everybody.

Continue reading “How to Feed Ten Billion: Lab-Made ‘Clean Meat’ Burgers are Future of Food” »

Dr. Aubrey de Grey of the of the SENS Research Foundation explains the OncoSENS approach to curing ALT-Cancer, the corresponding crowdunding campaign (https://www.lifespan.io/campaigns/sens-control-alt-delete-cancer/), and how this is a vital part of overcoming the ill-effects of aging.

This presentation is part of the Designing New Advances conference held by the Institute of Exponential Sciences in the Netherlands, orchestrated by Demian Hoed, and Lotte Van Norte.

Continue reading “Aubrey de Grey Explains SENS Anti-Cancer Strategy and Lifespan.io Campaign at D.N.A. Conference” »

https://www.youtube.com/watch?v=5HZsFMqqGJo

KEPLER 186F — LIFE AFTER EARTH — 2014 Documentary
* Our New Channel for Documentary 1080p HD — https://www.youtube.com/advexon

* Subscribe for more Scientific & Technological Videos
* Like & Share
* go to our website http://www.advexon.com

Continue reading “KEPLER 186F — LIFE AFTER EARTH — Documentary” »

California-based startup Ambrosia is starting clinical trials that will see older people pumped with blood from younger donors, in the hopes of rejuvenating their bodies.

Reversing and eliminating aging has always been one of the true Holy Grails of medical science. Like the search for the rumored Grail, the journey to eliminate aging will be a difficult one– and there is some doubt as to whether it is actually achievable.

Continue reading “Reversing Aging: Clinical Trials For ‘Young-to-Old’ Blood Transfusions Begin” »